This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring a boronate ester group, makes it particularly valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to construct carbon-carbon bonds in the development of pharmaceuticals. The thiomorpholine moiety enhances its potential as a building block for drug candidates, particularly in the design of compounds targeting neurological disorders or cancer. Additionally, its unique chemical properties may contribute to the development of novel enzyme inhibitors or receptor modulators, making it a versatile tool in drug discovery and optimization processes.